What is ICU Medical's restructuring, strategic transaction and integration?

ICU Medical (ICUI) reported restructuring, strategic transaction and integration of $16.8M in Q1 2026.

ICU Medical ICUI Restructuring, strategic transaction and integration

Revenue$530.2M-12.3%

Gross profit$206.2M-1.8%

Operating income$13.6M+5.4%

Net income$30.1M+295%

EPS (diluted)$1.20+290%

Cash & equivalents$288.3M-0.5%

Total debt$1.4B-17.5%

Total equity$2.1B+6.3%

Total assets$4.0B-4.1%

Operating cash flow$38.9M-24.2%

CapEx$11.3M-22.7%

Free cash flow$27.6M-24.8%

Market cap$3.39B-6.3%

Gross margin37.9%+2.8pp

Operating margin2%-0.7pp

Net margin-0.3%-0.2pp

FCF margin4.2%-1.2pp

Return on equity-0.4%-0.2pp

Debt / equity0.6×-0.2×

Current ratio2.3×-0.3×

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept icui:Restructuringandstrategictransaction.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

What is ICU Medical's restructuring, strategic transaction and integration?: ICU Medical (ICUI) reported restructuring, strategic transaction and integration of $16.8M in Q1 2026.
How has ICU Medical's restructuring, strategic transaction and integration changed year-over-year?: ICU Medical's restructuring, strategic transaction and integration increased by 0.6% year-over-year, from $16.7M to $16.8M.